Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

Chidambaram Medical College PG medico allegedly dies by suicide

DRRA4 minutes ago 0

Removed doctor claims safety warnings were ignored

DRRA43 minutes ago 0

Govt Doctors observe black day, demand revocation of doctors’ suspension at Palakkad Hospital

DRRA1 hour ago 0

DME Chhattisgarh invites applications for nursing admissions 2025, details

DRRA3 hours ago 0